1-25809791-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020451.3(SELENON):​c.981C>T​(p.Arg327Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0382 in 1,613,980 control chromosomes in the GnomAD database, including 1,486 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 73 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1413 hom. )

Consequence

SELENON
NM_020451.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.77
Variant links:
Genes affected
SELENON (HGNC:15999): (selenoprotein N) This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in this gene are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. SEPN1-related myopathy consists of 4 autosomal recessive disorders, originally thought to be separate entities: rigid spine muscular dystrophy (RSMD1), the classical form of multiminicore disease, desmin related myopathy with Mallory-body like inclusions, and congenital fiber-type disproportion (CFTD). This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. A second stop-codon redefinition element (SRE) adjacent to the UGA codon has been identified in this gene (PMID:15791204). SRE is a phylogenetically conserved stem-loop structure that stimulates readthrough at the UGA codon, and augments the Sec insertion efficiency by SECIS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 1-25809791-C-T is Benign according to our data. Variant chr1-25809791-C-T is described in ClinVar as [Benign]. Clinvar id is 95967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-25809791-C-T is described in Lovd as [Benign]. Variant chr1-25809791-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-2.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0269 (4095/152320) while in subpopulation NFE AF= 0.0434 (2949/68018). AF 95% confidence interval is 0.0421. There are 73 homozygotes in gnomad4. There are 1877 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 73 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SELENONNM_020451.3 linkc.981C>T p.Arg327Arg synonymous_variant Exon 7 of 13 ENST00000361547.7 NP_065184.2 Q9NZV5-1
SELENONNM_206926.2 linkc.879C>T p.Arg293Arg synonymous_variant Exon 6 of 12 NP_996809.1 Q9NZV5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SELENONENST00000361547.7 linkc.981C>T p.Arg327Arg synonymous_variant Exon 7 of 13 1 NM_020451.3 ENSP00000355141.2 Q9NZV5-1
SELENONENST00000374315.1 linkc.879C>T p.Arg293Arg synonymous_variant Exon 6 of 12 5 ENSP00000363434.1 Q9NZV5-2
SELENONENST00000354177.9 linkc.810C>T p.Arg270Arg synonymous_variant Exon 6 of 12 5 ENSP00000346109.5 H9KV50
SELENONENST00000494537.2 linkn.879C>T non_coding_transcript_exon_variant Exon 6 of 13 3 ENSP00000508308.1 A0A804HLD6

Frequencies

GnomAD3 genomes
AF:
0.0269
AC:
4096
AN:
152202
Hom.:
73
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00844
Gnomad AMI
AF:
0.0516
Gnomad AMR
AF:
0.0245
Gnomad ASJ
AF:
0.0210
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00684
Gnomad FIN
AF:
0.0187
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0434
Gnomad OTH
AF:
0.0306
GnomAD3 exomes
AF:
0.0256
AC:
6380
AN:
249420
Hom.:
114
AF XY:
0.0250
AC XY:
3380
AN XY:
135350
show subpopulations
Gnomad AFR exome
AF:
0.00735
Gnomad AMR exome
AF:
0.0193
Gnomad ASJ exome
AF:
0.0217
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00542
Gnomad FIN exome
AF:
0.0180
Gnomad NFE exome
AF:
0.0411
Gnomad OTH exome
AF:
0.0292
GnomAD4 exome
AF:
0.0393
AC:
57506
AN:
1461660
Hom.:
1413
Cov.:
32
AF XY:
0.0384
AC XY:
27902
AN XY:
727134
show subpopulations
Gnomad4 AFR exome
AF:
0.00600
Gnomad4 AMR exome
AF:
0.0195
Gnomad4 ASJ exome
AF:
0.0254
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00649
Gnomad4 FIN exome
AF:
0.0181
Gnomad4 NFE exome
AF:
0.0470
Gnomad4 OTH exome
AF:
0.0328
GnomAD4 genome
AF:
0.0269
AC:
4095
AN:
152320
Hom.:
73
Cov.:
32
AF XY:
0.0252
AC XY:
1877
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.00842
Gnomad4 AMR
AF:
0.0245
Gnomad4 ASJ
AF:
0.0210
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00663
Gnomad4 FIN
AF:
0.0187
Gnomad4 NFE
AF:
0.0434
Gnomad4 OTH
AF:
0.0303
Alfa
AF:
0.0372
Hom.:
53
Bravo
AF:
0.0268
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0376
EpiControl
AF:
0.0376

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Jan 13, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 29, 2012
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 29, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 10, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Arg327Arg in exon 7 of SEPN1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 3.8% (2526/66692) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs147587542). -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

SEPN1-related disorder Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Eichsfeld type congenital muscular dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.18
DANN
Benign
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147587542; hg19: chr1-26136282; COSMIC: COSV62524818; COSMIC: COSV62524818; API